Högskolan i Skövde

his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects of 1,25(OH)2D3 on Smad2 Activity in PC-3 Prostate Cancer Cells
University of Skövde, School of Life Sciences.
2009 (English)Student paper other, 5 credits / 7,5 HE creditsStudent thesis
Abstract [en]

The vitamin D metabolite 1,25(OH)2D3 has long been known to inhibit growth of prostate cancer cells and this mainly through a VDR-mediated pathway controlling target gene expression, resulting in cell cycle arrest, apoptosis and differentiation. Another major way inwhich 1,25(OH)2D3 inhibits cell growth in prostate cancer is via membrane-initiated steroid signalling, which triggers activation of signal cascades upon steroid binding to a receptor complex, leading to induction of genes regulating cell growth, proliferation and apoptosis. The main prostate cancer inhibiting membrane-initiated route is the TGFβ signalling pathway, elicited by the protein TGFβ. Another important protein downstream in this cascade is Smad2. In this study the early effects of 1,25(OH)2D3 on activated Smad2 levels in PC-3 prostate cancer cells were examined. PC-3 cells were incubated for 5, 10, 30 and 60 minutes as well as 24 and 40 hours both together with 1,25(OH)2D3 of the concentrations 10-10 and 107 M and without. An ELISA assay scanning for activated Smad2 was then performed on supernatants from both treated and untreated cells. This is a follow-up to an earlier study which examined the influence of 1,25(OH)2D3 on TGFβ levels using the same doses and similar time points and which found that 1,25(OH)2D3 initially lowered the level of active TGFβ, then increased it. The results of this study showed a statistically insignificant, time delayed 1,25(OH)2D3 mediated induction of the same pattern in the levels of active Smad2.

Place, publisher, year, edition, pages
2009. , p. 12
Keywords [en]
prostate cancer; PC-3; vitamin D; 1, 25(OH)2D3; TGFβ; Smad2; Smad3
National Category
Natural Sciences
Identifiers
URN: urn:nbn:se:his:diva-3807OAI: oai:DiVA.org:his-3807DiVA, id: diva2:304579
Presentation
(English)
Uppsok
Medicine
Supervisors
Examiners
Projects
Project Work in Biomedicine, Advanced Level, 7.5 ECTSAvailable from: 2010-03-23 Created: 2010-03-18 Last updated: 2010-03-23Bibliographically approved

Open Access in DiVA

fulltext(514 kB)226 downloads
File information
File name FULLTEXT01.pdfFile size 514 kBChecksum SHA-512
c9a9e8f8dd545ed44af98f06c280562d0855f50076a4107f88fd84a4fa91f14c788dd2ac31e9f2f304b15644700f7fa3679c5d2c9f834b75937615e91f8a452a
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Stahel, Anette
By organisation
School of Life Sciences
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 226 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 303 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf